The Right Question

Nancy L. Logan, MA, an individual associated with Baylor University's 2005-2006 C-Diff studies, shared results with a C-Diff-infected individual in Connecticut. The individual's blog comment relays the study's findings as described in email by Logan:

"A drug called Nitazoxanide has proven to be more effective than vanco or metronidazole. It has been used previously, and world-wide, to treat pediatric patients for Giardia (a bug that is, as it were, child's play when compared to this new strain of c-diff)."

Read about study NCT00304408 on clinicaltrials.gov.